Phreesia’s Alexandra Beneville Named One of MM+M’s ‘Women to Watch’ for 2023

Rhea-AI Summary

Phreesia has announced that Alexandra Beneville, Vice President of Life Sciences Content Strategy, has been named to MM+M's 2023 'Women to Watch' class, recognizing her as one of 18 influential women in the healthcare marketing field. Since joining Phreesia in August, Beneville has significantly impacted the company's Life Sciences strategy and operations, driving growth and enhancing diversity and inclusion. Phreesia, listed on the NYSE under the symbol PHR, focuses on empowering life sciences companies through tailored patient interactions and insights.

Positive

• Alexandra Beneville was recognized in MM+M's 2023 'Women to Watch' class, highlighting her leadership in healthcare marketing.
• Beneville's contributions have significantly impacted Phreesia's Life Sciences strategy and operations since her arrival in August.
• Phreesia's PatientConnect and PatientInsights offerings are designed to enhance patient engagement and understanding.

Negative

• None.

WILMINGTON, Del.--(BUSINESS WIRE)-- Phreesia is pleased to announce that the healthcare marketing industry trade publication MM+M has named Alexandra Beneville, Vice President, Life Sciences Content Strategy, to its Women to Watch class of 2023.

Now in its eighth year, the program honors the industry’s “leaders of tomorrow”—women who have inspired their colleagues and “represent the best of what this industry has to offer,” MM+M editor-in-chief Larry Dobrow said. Beneville was one of just 18 women to receive the distinction in 2023.

“I’m honored to be recognized by MM+M alongside a group of such accomplished women leaders,” Beneville said. “I’m incredibly proud of all that Phreesia’s Life Sciences team has accomplished in the last year and look forward to bringing important health content to more patients in 2023.”

Since joining Phreesia last August, Alex has become an integral part of the company’s leadership team, spearheading the growth and expansion of its Life Sciences content strategy and transforming the Life Sciences group’s structure and operations to support the company’s wider business goals. She is admired by her colleagues as a visionary leader and a champion for diversity and inclusion.

“We are thrilled to see Alex awarded this well-deserved honor,” said David Linetsky, Phreesia’s Senior Vice President, Life Sciences. “In just 8 months with Phreesia, Alex has already had a tremendous impact on our success, and we’re excited for all that’s to come under her guidance and leadership.”

About Phreesia Life Sciences

Phreesia empowers life sciences companies to connect with clinically relevant patients, delivering tailored health content in a one-to-one setting. Our PatientConnect offering identifies and motivates the right patients to initiate meaningful conversations, while our PatientInsights product enables our clients to better understand key patient populations.

Phreesia meets patients where they are, both virtually and in person, and reaches them at multiple touchpoints throughout their healthcare journey.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230317005012/en/

Press:

Carly Helfand

chelfand@phreesia.com

332-910-6768

Source: Phreesia

FAQ

Who was named to MM+M's 2023 'Women to Watch' class from Phreesia?

Alexandra Beneville, Vice President of Life Sciences Content Strategy, was recognized.

What is the significance of Alexandra Beneville's recognition in the press release?

Her recognition highlights her influence in the healthcare marketing industry and her contributions to Phreesia.

What does Phreesia focus on in its Life Sciences division?

Phreesia specializes in connecting life sciences companies with patients through tailored health content and insights.

What is the stock symbol for Phreesia?

Phreesia is listed on the NYSE under the symbol PHR.